Recent News for ALDR - Alder BioPharmaceuticals, Inc.

Date Title
Aug 16 Alder BioPharmaceuticals approaches rare status for a Seattle biotech
Aug 9 Alder BioPharmaceuticals (ALDR) Investor Presentation - Slideshow
Aug 8 Alder BioPharmaceuticals, Inc. (ALDR) CEO Bob Azelby on Q2 2019 Results - Earnings Call Transcript
Aug 7 Alder BioPharmaceuticals, Inc. (ALDR) Q2 2019 Earnings Call Transcript
Aug 7 Edited Transcript of ALDR earnings conference call or presentation 6-Aug-19 9:00pm GMT
Aug 6 Alder Bio EPS beats by $0.22
Aug 6 Alder BioPharmaceuticals® Reports Second Quarter 2019 Financial and Operating Results
Aug 6 The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering
Aug 2 Alder BioPharmaceuticals® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 1 Alder BioPharmaceuticals® to Present at Canaccord Genuity 39th Annual Growth Conference
Jul 30 Alder BioPharmaceuticals® to Host Conference Call to Discuss Second Quarter 2019 Financial and Operating Results
Jul 19 Alder Biopharmaceuticals Sees Hammer Chart Pattern: Time to Buy?
Jul 11 Alder BioPharmaceuticals® Presents New Data on Migraine-Free Months, Migraine Severity and Quality of Life, Demonstrating Eptinezumab’s Clinical Profile for Migraine Prevention
Jul 10 Goldman likes HCA in premarket analyst action
Jul 8 Alder BioPharmaceuticals® to Showcase 14 New Data Presentations Demonstrating Eptinezumab’s Migraine Prevention and Quality of Life Impact at American Headache Society Meeting
Jul 3 All You Need to Know About Alder BioPharmaceuticals (ALDR) Rating Upgrade to Buy
Jun 30 Is Alder Biopharmaceuticals Inc (ALDR) A Good Stock To Buy ?
Jun 19 Alder BioPharmaceuticals® to Webcast Upcoming Breakfast Symposium with Key Opinion Leaders
Jun 18 Alder BioPharmaceuticals® to Present at BMO Capital Markets 2019 Prescription for Success Healthcare Conference
Jun 4 Imagine Owning Alder BioPharmaceuticals (NASDAQ:ALDR) While The Price Tanked 65%
May 28 Goldman sees 17% upside in J&J in premarket analyst action
May 22 Edited Transcript of ALDR earnings conference call or presentation 8-May-18 9:00pm GMT
May 14 Alder BioPharmaceuticals® to Present at Two Upcoming May Investor Conferences
May 8 Alder's eptinezumab shows treatment effect in late-stage migraine study
May 8 Alder BioPharmaceuticals® Presents New Analysis of Patient-Reported Outcomes Following Eptinezumab Treatment for Migraine Prevention
Back to the Main ALDR Page...